Financials
Income statement
Fiscal date | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
---|---|---|---|---|
Total reported revenue | 24.8B | 24.7B | 16.9B | 14.3B |
Cost of revenue | 19.8B | 19.4B | 13.1B | 10.9B |
Gross profit | 5.1B | 5.3B | 3.8B | 3.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 1.1B | 2.1B | 1.2B | 1.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 151M | 121M | 57M | 48M |
Other income expense | — | — | — | — |
Pretax income | 871M | 2.0B | 96M | 1.6B |
Tax provision | 564M | 695M | -769M | 241M |
Net income | 308M | 1.3B | 866M | 1.4B |
Basic EPS | — | 4.4 | — | — |
Diluted EPS | — | 4.1 | — | — |
Basic average shares | — | 275.8M | — | — |
Diluted average shares | — | 275.8M | — | — |
EBITDA | 1.0B | 2.1B | 1.2B | 1.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -126M | -95M | -12M | -5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |